Stay updated with breaking news from Qure Contacts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
~ Patients treated with AMT-130 continue to show evidence of preserved neurological function with potential dose-dependent clinical benefits relative to an inclusion criteria-matched natural...
~ Patients treated with AMT-130 continue to show evidence of preserved neurological function with potential dose-dependent clinical benefits relative to an inclusion criteria-matched natural...
LEXINGTON, Mass. and AMSTERDAM, Dec. 08, 2023 -- uniQure N.V. , a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the grant...
Patient enrollment expected to begin in first half of 2024LEXINGTON, Mass. and AMSTERDAM, Nov. 29, 2023 -- uniQure N.V. , a leading gene therapy company advancing transformative therapies for...
Patient enrollment expected to begin in first half of 2024...